Bulletin
Investor Alert

Viatris Inc.

NAS: VTRS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 6:52 p.m.

/zigman2/quotes/209413137/composite

$

11.75

Change

-0.05 -0.42%

Volume

Volume 573,923

Quotes are delayed by 20 min

/zigman2/quotes/209413137/composite

Previous close

$ 11.69

$ 11.80

Change

+0.11 +0.94%

Day low

Day high

$11.61

$11.92

Open

52 week low

52 week high

$9.66

$15.92

Open

Company Description

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Gr...

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Valuation

P/E Ratio (with extraordinary items)

81.52

Price to Sales Ratio

0.92

Price to Book Ratio

0.80

Price to Cash Flow Ratio

5.42

Enterprise Value to EBITDA

7.39

Enterprise Value to Sales

2.05

Efficiency

Total Asset Turnover

0.31

Liquidity

Current Ratio

1.10

Quick Ratio

0.70

Cash Ratio

0.09

Profitability

Gross Margin

34.70

Operating Margin

9.34

Pretax Margin

-3.72

Net Margin

-7.11

Return on Assets

-2.18

Return on Equity

-5.84

Return on Total Capital

3.59

Capital Structure

Total Debt to Total Assets

42.62

Officers and Executives

Name Age Officer Since Title
Mr. Robert J. Coury 59 2020 Executive Chairman
Mr. Michael Goettler - 2020 Chief Executive Officer & Director
Mr. Rajiv Malik 59 2020 President & Director
Mr. Sanjeev Kumar Sethi - 2020 Chief Operating Officer
Mr. Sanjeev Narula 60 2020 Chief Financial Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/29/2022 Xiangyang Sean Ni
President, Greater China
102   Derivative/Non-derivative trans. at $0 per share. 0
03/29/2022 Xiangyang Sean Ni
President, Greater China
2,852   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Michael Goettler
Chief Executive Officer; Director
280   Derivative/Non-derivative trans. at $10.39 per share. 2,909
03/21/2022 Pauline F. M. van der Meer Mohr
Director
3   Derivative/Non-derivative trans. at $10.39 per share. 31
03/21/2022 Menassie Taddese
See Remarks
34   Derivative/Non-derivative trans. at $10.39 per share. 353
03/21/2022 Michael Goettler
Chief Executive Officer; Director
639   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Melina E. Higgins
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Mark W. Parrish
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 James Marshall Kilts
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Neil F. Dimick
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Harry A. Korman
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 JoEllen Lyons Dillon
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Richard A. Mark
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Pauline F. M. van der Meer Mohr
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Wyllie Don Cornwell
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Ian C. Read
Director
166   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2022 Menassie Taddese
See Remarks
80   Derivative/Non-derivative trans. at $0 per share. 0
03/15/2022 Michael Goettler
Chief Executive Officer; Director
50,352   Acquisition at $9.87 per share. 496,974
03/15/2022 Wyllie Don Cornwell
Director
2,700   Acquisition at $9.9 per share. 26,730
03/11/2022 Robert J. Coury
Executive Chairman; Director
250,000   Disposition at $10.07 per share. 2,517,500
03/09/2022 Robert J. Coury
Executive Chairman; Director
250,000   Disposition at $10.28 per share. 2,570,000
03/02/2022 Robert J. Coury
Executive Chairman; Director
1,195   Derivative/Non-derivative trans. at $10.48 per share. 12,523
03/02/2022 Robert J. Coury
Executive Chairman; Director
49,962   Derivative/Non-derivative trans. at $10.48 per share. 523,601
03/02/2022 Rajiv Malik
President; Director
699   Derivative/Non-derivative trans. at $10.48 per share. 7,325
03/02/2022 Rajiv Malik
President; Director
29,210   Derivative/Non-derivative trans. at $10.48 per share. 306,120
03/02/2022 Rajiv Malik
President; Director
22,884   Derivative/Non-derivative trans. at $10.48 per share. 239,824
03/02/2022 Rajiv Malik
President; Director
54,648   Derivative/Non-derivative trans. at $10.48 per share. 572,711
03/02/2022 Rajiv Malik
President; Director
14,562   Derivative/Non-derivative trans. at $10.48 per share. 152,609
03/02/2022 Anthony Mauro
See Remarks
311   Derivative/Non-derivative trans. at $10.48 per share. 3,259
03/02/2022 Anthony Mauro
See Remarks
12,983   Derivative/Non-derivative trans. at $10.48 per share. 136,061
03/02/2022 Anthony Mauro
See Remarks
10,614   Derivative/Non-derivative trans. at $10.48 per share. 111,234
03/02/2022 Anthony Mauro
See Remarks
25,344   Derivative/Non-derivative trans. at $10.48 per share. 265,605
03/02/2022 Anthony Mauro
See Remarks
6,820   Derivative/Non-derivative trans. at $10.48 per share. 71,473
03/02/2022 Michael Goettler
Chief Executive Officer; Director
883   Derivative/Non-derivative trans. at $10.48 per share. 9,253
03/02/2022 Michael Goettler
Chief Executive Officer; Director
36,918   Derivative/Non-derivative trans. at $10.48 per share. 386,900
03/02/2022 Brian S. Roman
Global General Counsel
138   Derivative/Non-derivative trans. at $10.48 per share. 1,446
03/02/2022 Brian S. Roman
Global General Counsel
5,719   Derivative/Non-derivative trans. at $10.48 per share. 59,935
03/02/2022 Brian S. Roman
Global General Counsel
2,159   Derivative/Non-derivative trans. at $10.48 per share. 22,626
03/02/2022 Brian S. Roman
Global General Counsel
5,742   Derivative/Non-derivative trans. at $10.48 per share. 60,176
03/02/2022 Brian S. Roman
Global General Counsel
1,714   Derivative/Non-derivative trans. at $10.48 per share. 17,962
03/02/2022 Paul B. Campbell
See Remarks
8   Derivative/Non-derivative trans. at $10.48 per share. 83
03/02/2022 Paul B. Campbell
See Remarks
147   Derivative/Non-derivative trans. at $10.48 per share. 1,540
03/02/2022 Paul B. Campbell
See Remarks
297   Derivative/Non-derivative trans. at $10.48 per share. 3,112
03/02/2022 Paul B. Campbell
See Remarks
6,128   Derivative/Non-derivative trans. at $10.48 per share. 64,221
03/02/2022 Paul B. Campbell
See Remarks
212   Derivative/Non-derivative trans. at $10.48 per share. 2,221
03/02/2022 Paul B. Campbell
See Remarks
3,003   Derivative/Non-derivative trans. at $10.48 per share. 31,471
03/02/2022 Paul B. Campbell
See Remarks
197   Derivative/Non-derivative trans. at $10.48 per share. 2,064
03/02/2022 Paul B. Campbell
See Remarks
6,779   Derivative/Non-derivative trans. at $10.48 per share. 71,043
03/02/2022 Paul B. Campbell
See Remarks
132   Derivative/Non-derivative trans. at $10.48 per share. 1,383
03/02/2022 Paul B. Campbell
See Remarks
2,027   Derivative/Non-derivative trans. at $10.48 per share. 21,242
03/02/2022 Andrew G. Cuneo
See Remarks
79   Derivative/Non-derivative trans. at $10.48 per share. 827
03/02/2022 Andrew G. Cuneo
See Remarks
3,259   Derivative/Non-derivative trans. at $10.48 per share. 34,154
03/02/2022 Andrew G. Cuneo
See Remarks
2,202   Derivative/Non-derivative trans. at $10.48 per share. 23,076
03/02/2022 Andrew G. Cuneo
See Remarks
4,321   Derivative/Non-derivative trans. at $10.48 per share. 45,284
03/02/2022 Andrew G. Cuneo
See Remarks
1,301   Derivative/Non-derivative trans. at $10.48 per share. 13,634
03/02/2022 Pauline F. M. van der Meer Mohr
Director
6   Derivative/Non-derivative trans. at $10.48 per share. 62
03/02/2022 Pauline F. M. van der Meer Mohr
Director
219   Derivative/Non-derivative trans. at $10.48 per share. 2,295
03/02/2022 Sanjeev Narula
Chief Financial Officer
272   Derivative/Non-derivative trans. at $10.48 per share. 2,850
03/02/2022 Sanjeev Narula
Chief Financial Officer
11,415   Derivative/Non-derivative trans. at $10.48 per share. 119,629
03/02/2022 Menassie Taddese
See Remarks
73   Derivative/Non-derivative trans. at $10.48 per share. 765
03/02/2022 Menassie Taddese
See Remarks
2,994   Derivative/Non-derivative trans. at $10.48 per share. 31,377
03/02/2022 Paul B. Campbell
See Remarks
1,629   Gift at $0 per share. 0
03/02/2022 Robert J. Coury
Executive Chairman; Director
2,409   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Robert J. Coury
Executive Chairman; Director
100,770   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Rajiv Malik
President; Director
1,606   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Rajiv Malik
President; Director
67,180   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Rajiv Malik
President; Director
52,631   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Rajiv Malik
President; Director
125,684   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Rajiv Malik
President; Director
33,516   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Anthony Mauro
See Remarks
714   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Anthony Mauro
See Remarks
29,858   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Anthony Mauro
See Remarks
24,409   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Anthony Mauro
See Remarks
58,288   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Anthony Mauro
See Remarks
15,544   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Michael Goettler
Chief Executive Officer; Director
2,030   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Michael Goettler
Chief Executive Officer; Director
84,908   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Melina E. Higgins
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Melina E. Higgins
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Mark W. Parrish
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Mark W. Parrish
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 James Marshall Kilts
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 James Marshall Kilts
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Neil F. Dimick
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Neil F. Dimick
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Brian S. Roman
Global General Counsel
313   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Brian S. Roman
Global General Counsel
13,063   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Harry A. Korman
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Harry A. Korman
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 JoEllen Lyons Dillon
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 JoEllen Lyons Dillon
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
21   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
870   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
622   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
6,865   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
577   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
15,483   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
385   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Paul B. Campbell
See Remarks
4,129   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Richard A. Mark
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Richard A. Mark
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Andrew G. Cuneo
See Remarks
176   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Andrew G. Cuneo
See Remarks
7,348   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Pauline F. M. van der Meer Mohr
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Pauline F. M. van der Meer Mohr
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Sanjeev Narula
Chief Financial Officer
625   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Sanjeev Narula
Chief Financial Officer
26,126   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Wyllie Don Cornwell
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Wyllie Don Cornwell
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Ian C. Read
Director
335   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Ian C. Read
Director
13,996   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Xiangyang Sean Ni
President, Greater China
172   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Xiangyang Sean Ni
President, Greater China
7,195   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Menassie Taddese
See Remarks
171   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Menassie Taddese
See Remarks
7,138   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Brian S. Roman
Global General Counsel
5,034   0
03/02/2022 Brian S. Roman
Global General Counsel
13,115   0
03/02/2022 Brian S. Roman
Global General Counsel
3,498   0
03/02/2022 Andrew G. Cuneo
See Remarks
4,576   0
03/02/2022 Andrew G. Cuneo
See Remarks
9,822   0
03/02/2022 Andrew G. Cuneo
See Remarks
2,620   0
03/02/2022 Paul B. Campbell
See Remarks
1,629   Gift at $0 per share. 0
02/28/2022 Michael Goettler
Chief Executive Officer; Director
561   Derivative/Non-derivative trans. at $11.01 per share. 6,176
02/28/2022 Michael Goettler
Chief Executive Officer; Director
23,461   Derivative/Non-derivative trans. at $11.01 per share. 258,305
02/28/2022 Menassie Taddese
See Remarks
78   Derivative/Non-derivative trans. at $11.01 per share. 858
02/28/2022 Menassie Taddese
See Remarks
3,218   Derivative/Non-derivative trans. at $11.01 per share. 35,430
02/28/2022 Michael Goettler
Chief Executive Officer; Director
1,290   Derivative/Non-derivative trans. at $0 per share. 0
02/28/2022 Michael Goettler
Chief Executive Officer; Director
53,958   Derivative/Non-derivative trans. at $0 per share. 0
02/28/2022 Menassie Taddese
See Remarks
162   Derivative/Non-derivative trans. at $0 per share. 0
02/28/2022 Menassie Taddese
See Remarks
6,752   Derivative/Non-derivative trans. at $0 per share. 0
12/30/2021 Robert J. Coury
Executive Chairman; Director
500,000   Gift at $0 per share. 0
12/30/2021 Robert J. Coury
Executive Chairman; Director
500,000   Gift at $0 per share. 0
06/24/2021 Robert J. Coury
Executive Chairman; Director
123,950   Derivative/Non-derivative trans. at $14.36 per share. 1,779,922
06/24/2021 Robert J. Coury
Executive Chairman; Director
250,000   Derivative/Non-derivative trans. at $0 per share. 0
05/21/2021 Wyllie Don Cornwell
Director
500   Acquisition at $15.45 per share. 7,725
/news/latest/company/us/vtrs

MarketWatch News on VTRS

  1. 8 S&P 500 Stocks That Are Still Negative Since the Pandemic Lows

    10:42 a.m. March 27, 2022

    - Barron's Online

  2. Viatris stock price target cut $14 from $21 at Truist

    8:49 a.m. March 2, 2022

    - Tomi Kilgore

  3. Viatris downgraded to market perform from outperform at Raymond James

    9:07 a.m. March 1, 2022

    - Tomi Kilgore

  4. Viatris now sees 2022 revenue of $17.0 bln to $17.5 bln; FactSet consensus $17.6 bln

    7:10 a.m. Feb. 28, 2022

    - Ciara Linnane

  5. Viatris shares jump 6% premarket

    7:11 a.m. Feb. 28, 2022

    - Ciara Linnane

  6. Viatris sees up to about $9 bln in pretax proceeds from asset sales, other moves by end 2023

    7:08 a.m. Feb. 28, 2022

    - Ciara Linnane

  7. Viatris board approves share buyback program of up to $1 bln

    7:09 a.m. Feb. 28, 2022

    - Ciara Linnane

  8. Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 bln

    7:06 a.m. Feb. 28, 2022

    - Ciara Linnane

  9. Viatris expects deal to close in second half

    7:06 a.m. Feb. 28, 2022

    - Ciara Linnane

  10. Viatris will own stake of at least 12.9% of Biocon Biologics

    7:07 a.m. Feb. 28, 2022

    - Ciara Linnane

  11. 10 Cheap Stocks for Volatile Markets

    11:06 a.m. Jan. 25, 2022

    - Barron's Online

  12. 4 Stocks for When Real Interest Rates Are Rising

    9:08 a.m. Jan. 20, 2022

    - Barron's Online

  13. 5 Companies That Began 2022 With Upbeat News on Dividends

    8:00 a.m. Jan. 8, 2022

    - Barron's Online

  14. The Cheapest Stocks in Each Sector of the S&P 500

    5:23 a.m. Dec. 13, 2021

    - Barron's Online

  15. Loading more headlines...
/news/nonmarketwatch/company/us/vtrs

Other News on VTRS

  1. These 20 stocks saw the biggest plunges during earnings season

    11:22 a.m. May 20, 2022

    - Seeking Alpha

  2. COURAGE CAPITAL MANAGEMENT LLC Buys 1, Sells 4 in 1st Quarter

    3:00 p.m. May 18, 2022

    - GuruFocus.com

  3. Teva raised to Neutral at BofA citing a near-term opioid deal

    9:28 a.m. May 17, 2022

    - Seeking Alpha

  4. 2 Stocks That Are Ridiculously Cheap Right Now

    7:52 a.m. May 14, 2022

    - Motley Fool

  5. Wall Street Breakfast: What Moved Markets

    7:52 a.m. May 14, 2022

    - Seeking Alpha

  6. 3 Dirt-Cheap Stocks You Can Buy Right Now

    7:04 a.m. May 14, 2022

    - Motley Fool

  7. Top 5 1st Quarter Trades of SKBA CAPITAL MANAGEMENT LLC

    3:00 p.m. May 12, 2022

    - GuruFocus.com

  8. Top 5 1st Quarter Trades of CINCINNATI CASUALTY CO

    1:00 p.m. May 12, 2022

    - GuruFocus.com

  9. Top 5 1st Quarter Trades of Chris Davis

    11:00 a.m. May 12, 2022

    - GuruFocus.com

  10. 10-Q: VIATRIS INC

    4:13 p.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. Why Viatris Stock Is Popping Today

    11:55 a.m. May 9, 2022

    - Motley Fool

  12. Viatris Inc. 2022 Q1 - Results - Earnings Call Presentation

    10:38 a.m. May 9, 2022

    - Seeking Alpha

  13. Viatris: A Cigar Butt With Many Puffs Left

    9:42 a.m. May 9, 2022

    - Seeking Alpha

  14. Loading more headlines...

At a Glance

Viatris, Inc.

Robert J. Coury Global Center

1000 Mylan Boulevard

Canonsburg, Pennsylvania 15317

Phone

1 7245141800

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$17.86B

Net Income

$-1.27B

Employees

37,000

/news/pressrelease/company/us/vtrs

Press Releases on VTRS

  1. S&P 500 Movers: ILMN, VTRS

    12:27 p.m. May 9, 2022

    - MarketNewsVideo.com

  2. Viatris Reports Strong First-Quarter 2022 Results

    6:59 a.m. May 9, 2022

    - PR Newswire - PRF

  3. Friday's ETF with Unusual Volume: IXJ

    3:20 p.m. March 25, 2022

    - MarketNewsVideo.com

  4. Viatris Defeats Biogen's Attempt to Revive Tecfidera Patent

    2:55 p.m. March 17, 2022

    - PR Newswire - PRF

  5. S&P 500 Movers: IPGP, KR

    11:26 a.m. March 3, 2022

    - MarketNewsVideo.com

  6. Viatris to Participate in Upcoming Investor Conferences

    5:30 p.m. March 1, 2022

    - PR Newswire - PRF

  7. S&P 500 Movers: VTRS, TGT

    11:30 a.m. March 1, 2022

    - MarketNewsVideo.com

  8. S&P 500 Movers: VTRS, SEDG

    11:25 a.m. Feb. 28, 2022

    - MarketNewsVideo.com

  9. Loading more headlines...
Link to MarketWatch's Slice.